BACKGROUND The effectiveness of HAART is shown by an extraordinary decrease in mortality rate, improvement in HIV related quality of life (QOL) and increase in life expectancy. As a result, many people living with HIV/AIDS will age in coming years. However, the interaction of aging with health outcomes in HIV is largely unexplored in Canada. Yet, it is a critical priority for long-term care and management for older people with HIV.